PITOZINAMERAN
UNII 8VLF8J3FR3

Substance Identification & Data

This profile provides standardized clinical and technical data for Pitozinameran, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8VLF8J3FR3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2920299-36-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
8VLF8J3FR3
CAS Registry Number
2920299-36-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
PITOZINAMERAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C203099
National Cancer Institute reference terminology for clinical and research data.
INN ID
13089
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pitozinameran. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PITOZINAMERAN

Common Names & Synonyms

MESSENGER RNA (MRNA), 5'-CAPPED, ENCODING A FULL-LENGTH, CODON-OPTIMISED PRE-FUSION STABILISED CONFORMATION VARIANT (K982P AND V983P) OF THE SARS-COV-2 (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2) SPIKE (S) GLYCOPROTEIN (OMICRON SUB-LINEAGE XBB.1.16; BASED UPON GISAID:EPI_ISL_16835403), FLANKED BY 5' AND 3' UNTRANSLATED REGIONS AND A 3'POLYADENYLATION (POLYA) TAIL, CONTAINS N1-METHYLPSEUDOURIDINE INSTEAD OF URIDINE (ALL-U>M1.PSI.)
PITOZINAMERAN [INN]
RNA (RECOMBINANT 5'-(1,2-((3'-O-METHYL)M7G-(5'->5')-PPP-AM))-CAPPED ALL URIDINE->N1-METHYLPSEUDOURIDINE-SUBSTITUTED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN SECRETORY SIGNAL PEPTIDE PLUS CODON-OPTIMIZED PRE-FUSION SPIKE GLYCOPROTEIN XBB.1.16 VARIANT (982-PROLINE,983-PROLINE)-SPECIFYING PLUS 5'- AND 3'-UNTRANSLATED FLANKING REGION-CONTAINING POLY(A)-TAILED MESSENGER RBP020.31), INNER SALT

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus